
Evolvere BioSciences YC Application
Evolvere BioSciences went through Y Combinator in the Summer 2024 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Summer 2024
- Industry
- HealthcareTherapeutics
- Team size
- 3
- Status
- Active
- Launched
- 2024
Founders
Adam WinnifrithFounder
Piotr JedryszekFounder
Weronika SlesakFounder
What Evolvere BioSciences does
🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. ☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈. 🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩⚕️. We are a team of biochemists and evolutionary biologists who met at the University of Oxford.
Evolvere BioSciences's YC application, reconstructed
Y Combinator application
Evolvere BioSciences, Summer 2024 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Evolvere BioSciences
Next-gen antibiotics outpace bacterial resistance
We build computational models that predict how bacteria will evolve resistance to antibiotics. Using those forecasts, we design antibiotics that bacteria can't easily outsmart, targeting only harmful bacteria and sparing beneficial microbes and human cells.
We live in Oxford, England, and would base the company there after YC.
We're rooted in Oxford because we met here at the University of Oxford as biochemists and evolutionary biologists. The region's scientific environment and access to expertise are vital for our work.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Evolvere BioSciences YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Evolvere BioSciences's public data (launch notes, founder backgrounds, product description). It shows how a company like Evolvere BioSciences would present itself to YC, not the text they submitted.
What YC batch was Evolvere BioSciences in?
Evolvere BioSciences was part of the Y Combinator Summer 2024 batch.
Who founded Evolvere BioSciences?
Evolvere BioSciences was founded by Adam Winnifrith, Piotr Jedryszek, Weronika Slesak.
What does Evolvere BioSciences do?
Making Next-Generation Antibiotics that Outpace Bacterial Evolution
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Evolvere BioSciences's application, and every other YC batch, is in YC Insights.